Home blood glucose monitors
This article was originally published in The Gray Sheet
Executive Summary
National Association for Medical Equipment Suppliers asks Health Care Financing Administration "to reconsider issuing the proposed fee reduction [for home blood glucose monitors] until adequate and appropriate manufacturing and market information, as opposed to simple wholesale catalog pricing, has been obtained and considered." In addition, NAMES argues that the pricing limit should not be applied retroactively to Jan. 1. HCFA published its proposal in the Jan. 6 Federal Register ("The Gray Sheet" Jan. 10, In Brief)